SEC 13F Intelligence

Argyle Capital Management, LLC / BMY

Argyle Capital Management, LLC’s Bristol-Myers Squibb Co Position

Does Argyle Capital Management, LLC own Bristol-Myers Squibb Co (BMY)? Yes71.2K shares worth $4M (+1.40% of its 13F portfolio) as of Q1 2026, down from 72.0K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
71.2K
% of Portfolio
+1.40%
Quarters Held
30
currently held

Position History BMY

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $4MQ2 ’19: $4MQ3 ’19: $4MQ4 ’19: $5MQ4 ’19Q1 ’20: $4MQ2 ’20: $5MQ3 ’20: $5MQ4 ’20: $5MQ4 ’20Q1 ’21: $5MQ2 ’21: $5MQ3 ’21: $5MQ4 ’21: $5MQ4 ’21Q1 ’22: $5MQ2 ’22: $6MQ3 ’22: $5MQ4 ’22: $5MQ4 ’22Q1 ’23: $5MQ2 ’23: $4MQ3 ’23: $4MQ4 ’23: $3MQ4 ’23Q1 ’24: $4MQ2 ’24: $3MQ3 ’24: $3MQ4 ’24: $4MQ4 ’24Q1 ’25: $4MQ2 ’25: $3MQ3 ’25: $3MQ4 ’25: $4MQ4 ’25Q1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202671.2K$4M+1.40%
Q4 202572.0K$4M+1.30%
Q3 202568.7K$3M+1.07%
Q2 202568.9K$3M+1.16%
Q1 202568.7K$4M+1.56%
Q4 202467.4K$4M+1.50%
Q3 202464.8K$3M+1.34%
Q2 202464.1K$3M+1.09%
Q1 202465.5K$4M+1.37%
Q4 202364.6K$3M+1.37%
Q3 202372.8K$4M+1.55%
Q2 202368.2K$4M+1.57%
Q1 202373.7K$5M+1.80%
Q4 202274.1K$5M+1.83%
Q3 202274.1K$5M+2.05%
Q2 202274.1K$6M+2.05%
Q1 202274.7K$5M+1.78%
Q4 202178.9K$5M+1.54%
Q3 202178.9K$5M+1.55%
Q2 202178.9K$5M+1.70%
Q1 202178.9K$5M+1.68%
Q4 202078.9K$5M+1.82%
Q3 202079.1K$5M+1.95%
Q2 202079.9K$5M+1.97%
Q1 202080.2K$4M+2.11%
Q4 201980.3K$5M+1.83%
Q3 201981.2K$4M+1.56%
Q2 201980.6K$4M+1.39%
Q1 201980.4K$4M+1.47%
Q4 201880.4K$4M+1.77%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of BMY.